Pfizer (PFE)

Investing Cash Flow

-$5.69B

TTM · Period ending: · USD

PFE logo

PFE Investing Cash Flow

Latest reported-$5.69B
PFE TTM Cash from Investing (-$329.00M → -$5.69B)
High-resolution chart · PNG

PFE investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pfizer Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
-5,685,000,000
-3,840,000,000
-1,351,000,000
3,172,000,000
3,545,000,000
4,194,000,000
2,652,000,000
-6,721,000,000
-3,776,000,000
-33,861,000,000
-32,278,000,000
-25,692,000,000
-27,207,000,000
-13,035,000,000
-15,783,000,000
-13,959,000,000
-23,408,000,000
-20,232,000,000
-22,546,000,000
-11,630,000,000
-1,073,000,000
-5,947,000,000
-4,271,000,000
-15,434,000,000
-22,675,000,000
-11,566,000,000
-3,945,000,000
-1,876,000,000
1,980,000,000
2,408,000,000
4,525,000,000
510,000,000
418,000,000
154,000,000
-4,741,000,000
-3,069,000,000
-4,454,000,000
-7,394,000,000
-7,811,000,000
-6,928,000,000
-7,790,000,000
-5,217,000,000
-2,980,000,000
-2,270,000,000
438,000,000
1,036,000,000
-5,654,000,000
-4,060,000,000
-2,136,000,000
207,000,000
-10,625,000,000
-3,868,000,000
-3,504,000,000
-5,227,000,000
6,154,000,000
216,000,000
678,000,000
1,926,000,000
2,200,000,000
-4,344,000,000
-8,439,000,000
-9,161,000,000
-492,000,000
786,000,000
4,368,000,000
-8,244,000,000
-31,272,000,000
-29,685,000,000
-30,494,000,000
-20,985,000,000
-12,835,000,000
-12,854,000,000
-11,700,000,000
-8,960,000,000
795,000,000
4,029,000,000
4,326,000,000
3,941,000,000
5,101,000,000
-3,113,000,000
-4,919,000,000
3,045,000,000
-5,072,000,000
18,000,000
1,517,000,000
-8,387,000,000
-9,422,000,000
-5,834,000,000
-5,765,000,000
3,000,000,000
4,838,000,000
3,355,000,000
2,456,000,000
-5,145,000,000
-4,338,000,000
-5,809,000,000
-6,440,000,000
-7,042,000,000
-7,225,000,000
-5,563,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.